Go Pro
→ Do NOT Buy SpaceX – Do This Instead (From Stansberry Research) (Ad)tc pixel
OTCMKTS:POSC

Positron Q1 2025 Earnings Report

Positron logo
$1.87 +0.03 (+1.52%)
As of 09/28/2026 12:23 PM Eastern
ProfileEarnings History

Positron EPS Results

Actual EPS
-$0.05
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Positron Revenue Results

Actual Revenue
$0.12 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Positron Announcement Details

Quarter
Q1 2025
Date
5/15/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Positron Earnings Headlines

Positron Secures Multiple PET-CT Orders Amid Accelerating Shift to Cardiac PET
July 20, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/20/3329801/0/en/positron-secures-multiple-pet-ct-orders-amid-accelerating-shift-to-cardiac-pet.html
Positron Corp Stock Price History
May 20, 2026  |  investing.comhttps://www.investing.com/equities/positron-corp-historical-data
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
 |  Stansberry Research (Ad)
Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices
February 17, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/17/3239416/0/en/positron-corporation-secures-multiple-pet-ct-orders-from-leading-nuclear-cardiologist-practices.html
Positron Corporation Raises $2 Million to Expand Market Presence and Growth Initiatives
December 31, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/positron-corporation-raises-2-million-to-expand-market-presence-and-growth-initiatives-1035676436
Positron Corporation Announces Its Transition to a Reporting SEC Company
November 17, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/11/17/3189247/0/en/positron-corporation-announces-its-transition-to-a-reporting-sec-company.html
See More Positron Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Positron? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Positron and other key companies, straight to your email.

About Positron

Positron (OTCMKTS:POSC) Corporation is a medical technology company focused on positron emission tomography (PET), an imaging technique used to evaluate physiological activity in the body. The company’s business has centered on developing, manufacturing and commercializing PET imaging systems and related technologies for healthcare providers.

Positron has also been associated with radiopharmaceutical products and services that support PET procedures, as well as the installation, maintenance and servicing of imaging equipment. Its solutions are primarily intended for diagnostic applications, including cardiac and other clinical imaging uses.

Publicly available information about Positron Corporation’s current operations, geographic reach and leadership is limited. The company’s activities have historically been directed toward the medical-imaging market, but specific details regarding its present product portfolio and management team should be confirmed through its latest regulatory filings.

View Positron Profile
Earnings Tools